Literature DB >> 15708996

Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest.

Tomoshige Kino1, Alexander Gragerov, Antonio Valentin, Maria Tsopanomihalou, Galina Ilyina-Gragerova, Rebecca Erwin-Cohen, George P Chrousos, George N Pavlakis.   

Abstract

Vpr and selected mutants were used in a Saccharomyces cerevisiae two-hybrid screen to identify cellular interactors. We found Vpr interacted with 14-3-3 proteins, a family regulating a multitude of proteins in the cell. Vpr mutant R80A, which is inactive in cell cycle arrest, did not interact with 14-3-3. 14-3-3 proteins regulate the G(2)/M transition by inactivating Cdc25C phosphatase via binding to the phosphorylated serine residue at position 216 of Cdc25C. 14-3-3 overexpression in human cells synergized with Vpr in the arrest of cell cycle. Vpr did not arrest efficiently cells not expressing 14-3-3sigma. This indicated that a full complement of 14-3-3 proteins is necessary for optimal Vpr function on the cell cycle. Mutational analysis showed that the C-terminal portion of Vpr, known to harbor its cell cycle-arresting activity, bound directly to the C-terminal part of 14-3-3, outside of its phosphopeptide-binding pocket. Vpr expression shifted localization of the mutant Cdc25C S216A to the cytoplasm, indicating that Vpr promotes the association of 14-3-3 and Cdc25C, independently of the presence of serine 216. Immunoprecipitations of cell extracts indicated the presence of triple complexes (Vpr/14-3-3/Cdc25C). These results indicate that Vpr promotes cell cycle arrest at the G(2)/M phase by facilitating association of 14-3-3 and Cdc25C independently of the latter's phosphorylation status.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708996      PMCID: PMC548435          DOI: 10.1128/JVI.79.5.2780-2787.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

2.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1.

Authors:  Y Zeng; K C Forbes; Z Wu; S Moreno; H Piwnica-Worms; T Enoch
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

3.  Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein.

Authors:  A Lopez-Girona; B Furnari; O Mondesert; P Russell
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

4.  Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr.

Authors:  M Masuda; Y Nagai; N Oshima; K Tanaka; H Murakami; H Igarashi; H Okayama
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Tumor necrosis factor alpha receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  J Biol Chem       Date:  2002-12-10       Impact factor: 5.157

6.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 7.  New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level.

Authors:  P Boya; B Roques; G Kroemer
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

8.  Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.

Authors:  F Re; D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.

Authors:  P Di Marzio; S Choe; M Ebright; R Knoblauch; N R Landau
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins.

Authors:  I Marzo; C Brenner; N Zamzami; S A Susin; G Beutner; D Brdiczka; R Rémy; Z H Xie; J C Reed; G Kroemer
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more
  31 in total

Review 1.  Virus manipulation of cell cycle.

Authors:  R Nascimento; H Costa; R M E Parkhouse
Journal:  Protoplasma       Date:  2011-10-11       Impact factor: 3.356

2.  HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest.

Authors:  Zhibin Liang; Ruikang Liu; Yongquan Lin; Chen Liang; Juan Tan; Wentao Qiao
Journal:  Virol Sin       Date:  2015-12-14       Impact factor: 4.327

3.  Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle.

Authors:  Kasia Hrecka; Magdalena Gierszewska; Smita Srivastava; Lukasz Kozaczkiewicz; Selene K Swanson; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

Review 4.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

5.  Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells.

Authors:  Jiradej Makjaroen; Poorichaya Somparn; Kenneth Hodge; Witthaya Poomipak; Nattiya Hirankarn; Trairak Pisitkun
Journal:  Mol Cell Proteomics       Date:  2018-08-10       Impact factor: 5.911

6.  Formation of nsP3-specific protein complexes during Sindbis virus replication.

Authors:  Elena Frolova; Rodion Gorchakov; Natalia Garmashova; Svetlana Atasheva; Leoncio A Vergara; Ilya Frolov
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 7.  Vpr-host interactions during HIV-1 viral life cycle.

Authors:  Richard Y Zhao; Ge Li; Michael I Bukrinsky
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-12       Impact factor: 4.147

8.  Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1.

Authors:  Jeffrey H Ringrose; Rienk E Jeeninga; Ben Berkhout; Dave Speijer
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.

Authors:  Sylvain Huard; Robert T Elder; Dong Liang; Ge Li; Richard Y Zhao
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.

Authors:  Takamasa Ichijo; George P Chrousos; Tomoshige Kino
Journal:  Mol Cell Endocrinol       Date:  2007-11-17       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.